Agreements reached under this partnership
Business alliance- 1
Agreement on the basic terms of a U.S. sales partnership
- 2
Discussions on the detailed terms of an exclusive sales license agreement
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
Projected sales volumes for the next several years are expected to exceed the assumptions made when the basic terms were agreed.
As the earnings outlook for this product remains uncertain, there is no change to the earnings forecast for the fiscal year ending December 2026. The company will promptly disclose any impact once it becomes clear.
| Item | Details |
|---|---|
| Name of alliance partner | Terrain Pharmaceuticals |
| Alliance partner's business activities | Development and sale of topical analgesics. Through a nationwide distribution network comprising independent retail pharmacies, specialty pharmacies and healthcare institutions, the company markets prescription and over-the-counter topical patches and semisolid formulations, including products based on lidocaine and NSAIDs. |
| Alliance partner's location | Reno, Nevada, U.S. |
| Type of alliance | Business alliance |
| Details of the alliance | Agreement on the basic terms of a U.S. sales partnership, Discussions on the detailed terms of an exclusive sales license agreement |
| Numerical targets under the alliance | Projected sales volumes for the next several years are expected to exceed the assumptions made when the basic terms were agreed. |
| Contract Date | August 2026 (expected) |
| Impact on Business Performance | As the earnings outlook for this product remains uncertain, there is no change to the earnings forecast for the fiscal year ending December 2026. The company will promptly disclose any impact once it becomes clear. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Projected sales volumes for the next several years are expected to exceed the assumptions made when the basic terms were agreed, and reviewing the sales strategy, supply plan and contractual terms is taking time.